Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

An international team of researchers led by Professor Morris Brown FRS at Queen Mary University of London found that ...

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

AstraZeneca Plc’s experimental hypertension drug Baxdrostat reduced the blood pressure of patients who have an uncontrolled ...

When you have a nosebleed, it can be related to medications, health conditions, or simply dry air. Here's what you need to ...

High blood pressure is a very common condition, and many people try to manage it with a combination of healthy habits and ...

NBC News asked experts what they would recommend instead to ease nasal congestion now that oral phenylephrine has been deemed ineffective.

The FDA recently announced plans to phase out the key ingredient in some cold and allergy pills. For consumers it will likely mean switching to alternatives, including nasal sprays or older oral ...

The drug is still considered effective in nasal sprays, though those are much less popular. A decongestant pill containing phenylephrine is displayed for a photograph in Philadelphia on Monday ...

For consumers, the change will likely mean switching to alternatives, including nasal sprays or older oral decongestants that were moved behind the pharmacy counter almost two decades ago.

FDA says decongestant in many cold medicines doesn’t work. So what does? The most popular nasal decongestant on US pharmacy shelves may not be there much longer ...

What the FDA committee says about decongestant pills An FDA panel met and decided that the current data doesn’t support the recommendation of oral phenylephrine as a nasal decongestant.